Intel Corp (INTC)

Momentum is only half the battle. Their underlying companies still need to justify the continued bullishness of their stocks.

Intel's surging data center business could power another strong year in 2027, and its valuation leaves room to run.

An investment in TSMC today could easily triple in value over the next four years.

ASML is the most important semiconductor equipment maker in the world.

What Happened? A number of stocks fell in the afternoon session after investors weighed escalating borrowing costs and Federal Reserve remarks emphasizing pr...

Chipmakers face selling pressure while healthcare and financial stocks gain ground, today, Oct. 16, 2026.

While retail investors trimmed Palantir shares in August, analyst upgrades and low institutional ownership suggest Wall Street may be driving PLTR's next move ahead of Q3 earnings.

Marvell Technology's long-term guidance suggests that the stock could become a multibagger.

Some look like bargains, but others could be value traps.

Tech stocks could crash any day now -- but they also might not be overpriced.

AI Maverick Intel (OTCID: AIMV) announced that it has entered into a definitive share purchase agreement to acquire Heal Access Canada Inc., an artificial intelligence (“AI”) healthcare technology company, from its controlling stockholder, HEAL Group Holdings Inc. The transaction includes $5 million in consideration through a secured, two-year promissory note bearing 10% annual interest, plus 20 million exchangeable shares convertible into AIMV common stock. Heal Access operates an AI-powered healthcare intelligence platform that integrates patient information and supports clinical workflows. The platform is operational in five countries and serves more than 118,000 patients. The acquisition remains subject to several closing conditions, including at least $6 million in financing and independent special committee ratification.

What Happened? A number of stocks fell in the morning session after hotter-than-expected inflation data compounded fears that elevated borrowing costs will c...

One designs the chips, the other builds the machines, but their financial health and risk profiles tell very different stories.

Intel's foundry turnaround has resulted in heavy losses and negative free cash flow, while Qualcomm generates robust cash with half the valuation multiple.

This company has the right combination of chips to meet agentic AI's processing needs.

The stock market faces several headwinds, and its elevated valuation could lead to a sharp correction.

Supply constraints might not be what's holding back companies from buying more AI chips.

It could, but not in the way you might think.

An explosion at the chipmaker's facility in Israel gave investors pause.

Tesla plans to build and operate its own AI chip fab, Terafab, raising questions about costs and execution ahead of its Oct. 21 earnings report amid a stretched valuation.

Nano-X Imaging Ltd. (NASDAQ: NNOX) (“Nanox”), an innovative technology company, is advancing Nanox.AI’s commercial and technology strategy through two developments aimed at expanding the use of AI in medical imaging. An exclusive three-year reseller agreement with Vertec Scientific, including minimum annual license commitments, establishes a dedicated UK channel for HealthOST, an AI-powered software solution that delivers qualitative and quantitative analysis of spinal CT images to help clinicians evaluate and assess spinal musculoskeletal disease, including osteoporosis. Separately, Nanox.AI has optimized its imaging AI framework for Intel Core Ultra processors using OpenVINO, demonstrating the potential to run AI inference locally on hospital hardware and reduce reliance on cloud connectivity. Together, these developments support Nanox.AI’s strategy of extracting additional clinical value from already performed scans while expanding commercial reach and offering healthcare providers more flexible deployment options.